GMP IPO Watch
Sai Parenteral’s IPO Day 3: A High-Premium Pharma Play—Steady Progress or Overvalued?
Hyderabad-based Sai Parenteral's enters the final stretch of its ₹409 crore IPO. With a pr...
Read Article
S
Mainboard IPO
LISTED
NSE, BSE
SAIPARENTERALS
Sai Parenteral's IPO
Sai Parenteral's IPO details, live grey market premium (GMP), dates, price band, lot size, subscription & review.
Live GMP Today
₹8
+2.0%
Est. Listing: ₹400.00
Price Band
₹372 - ₹392
Per equity share
Lot Size
38 Shares
Min Invest: ₹14,896
Issue Size
₹392 Cr
Total Public Offering
Issue Dates
23 March 2026 – 26 March 2026
Bidding period
Subscription
0.05x
Total overall demand
Sai Parenteral's IPO Details
Key facts at a glance| IPO Open Date | 23 March 2026 | IPO Close Date | 26 March 2026 |
|---|---|---|---|
| Basis of Allotment | TBA | Listing Date | 1 April 2026 |
| Price Band | ₹372 - ₹392 per share | Face Value | ₹10 per share |
| Market Lot Size | 38 Shares | Min Investment (Retail) | ₹14,896 |
| Total Issue Size | ₹392 Cr | Issue Type | Book Built Issue IPO |
| Fresh Issue | — | Offer for Sale (OFS) | — |
| Listing At | NSE, BSE | Issue Category | Mainboard Issue |
| Registrar | TBA | ||
Sai Parenteral's IPO Timetable (Tentative Dates)
| Event | Tentative Date | Status |
|---|---|---|
| IPO Open Date | 23 March 2026 | Confirmed |
| IPO Close Date | 26 March 2026 | Confirmed |
| Basis of Allotment | TBA | Tentative |
| Initiation of Refunds | TBA | Tentative |
| Credit of Shares to Demat | TBA | Tentative |
| IPO Listing Date | 1 April 2026 | Tentative |
| Cut-off time for UPI Mandate Confirmation | 5:00 PM on Closing Day | Deadline |
* Note: Timelines are tentative and subject to regulatory confirmation. UPI mandate approvals must be completed by 5:00 PM on the IPO closing day.
Sai Parenteral's IPO Lot Size & Investment Details
Application limits for Retail and HNI investors| Application Category | Lots | Shares | Amount (at Cut-off) |
|---|---|---|---|
| Retail (Min) | 1 Lot | 38 Shares | ₹14,896 |
| Retail (Max) | 13 Lots | 494 Shares | ₹1,93,648 |
| S-HNI (Min) | 14 Lots | 532 Shares | ₹2,08,544 |
| S-HNI (Max) | 67 Lots | 2,546 Shares | ₹9,98,032 |
| B-HNI (Min) | 68 Lots | 2,584 Shares | ₹10,12,928 |
Sai Parenteral's IPO Live GMP & Movement History
Daily unofficial grey market trends
Current Grey Market Premium
₹8 +2.0%
Estimated Listing Price
₹400.00
| Date | IPO GMP (₹) | Estimated Listing Price | Estimated Listing Gain (%) |
|---|---|---|---|
| 25 Mar 2026 | ₹0 | ₹392.00 | +0.00% |
| 23 Mar 2026 | ₹0 | ₹392.00 | +0.00% |
| 19 Mar 2026 | ₹0 | ₹392.00 | +0.00% |
Disclaimer: Grey Market Premium (GMP) figures are purely unofficial and indicative rates traded in the unregulated grey market. GMP is highly volatile and does not guarantee the actual listing price. Always consult a SEBI registered investment advisor before bidding.
Sai Parenteral's IPO Subscription Status
Demand breakdown by investor category
Retail
0.03x
QIB
0.00x
NII / HNI
—
Total
0.05x
About Sai Parenteral's
Sai Parenteral’s IPO is a mainboard public issue of a pharmaceutical company engaged in the manufacturing of branded generic formulations and providing contract development and manufacturing (CDMO) services across domestic and international markets. The IPO comprises a mix of fresh issue (around ₹285 crore) and an offer for sale, with proceeds primarily aimed at capacity expansion, R&D development, debt repayment, and working capital needs. The issue opened on 24 March 2026 and closed on 27 March 2026, with a price band of ₹372–₹392 per share, attracting attention due to its presence in the growing pharmaceutical and export-focused segment. With a diversified product portfolio and improving financial performance, the company operates in a high-growth pharma sector, offering potential long-term opportunities for investors.
Sai Parenteral's IPO Reservation & Share Quotas
| Investor Category | Shares Offered | Shares (%) |
|---|---|---|
| Anchor Investor | — Shares | —% |
| QIB (Ex. Anchor) | — Shares | 50% |
| NII | — Shares | 15% |
| Retail | — Shares | 35% |
Sai Parenteral's IPO Anchor Investors
| Anchor Bidding Date | March 23, 2026 |
|---|---|
| Shares Offered | — Shares |
| Anchor Size | ₹ — Cr. |
| Lock-in Period (50% Shares - 30 Days) | 2026 |
| Lock-in Period (50% Shares - 90 Days) | 2026 |
Sai Parenteral's IPO Important Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 24 Mar 2026 |
| IPO Close Date | 27 Mar 2026 |
| Basis of Allotment | - |
| Refunds | - |
| Credit to Demat Account | - |
| IPO Listing Date | 02 Apr 2026 |
Note: The timeline for Sai Parenteral's IPO is tentative and subject to change.
Sai Parenteral s IPO Promoters & Holding Pattern
| Particular | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 3,69,08,823 | 61.23% |
| Promoter Holding Post Issue | 4,41,79,231 | - |
| Promoters |
|---|
| Anil Kumar Karusala, Vijitha Gorrepati and Karusala Aruna |
Sai Parenteral's Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
About Sai Parenteral s IPO
Sai Parenteral’s Ltd., founded in 2001, is one of the leading pharmaceutical companies focused on R&D and manufacturing of pharmaceutical products. The firm operates in 2 main business areas: makes and sells its own branded medicines, and also manufactures medicines for other companies internationally. Its product offerings include a wide range of medicines for various health conditions, like cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals, and supplements (VMS), analgesics, and dermatology.
Its medicines are available in various forms like tablets, injections, and syrups. Sai Parenteral’s major clients are government agencies, pharmaceutical companies, public and private hospitals, and large distributors in India. The firm operates 5 manufacturing facilities in India, mainly located in Hyderabad, known for developing medicines with international quality certifications.
Sai Parenteral's Company Financial Report
To Be Updated Soon
Sai Parenteral's Company Valuation & Key Performance Indicators
To Be Updated Soon
Sai Parenteral's Peer Group Comparison
To Be Updated Soon
Sai Parenteral's Lead Managers & Merchant Bankers
- Arihant Capital Markets Ltd.
Sai Parenteral's IPO FAQs
Sai Parenteral's IPO opens for subscription on 23 March 2026 and closes on 26 March 2026.
The price band for Sai Parenteral's IPO is set at ₹372.00 to ₹392.00 per share.
The minimum market lot size is 38 shares. A retail investor can apply for a minimum of 1 lot requiring an investment of 38 Shares (₹14,896).
The latest Grey Market Premium (GMP) for Sai Parenteral's IPO is ₹8.00. GMP represents the unofficial premium at which shares trade prior to listing.
The basis of allotment for Sai Parenteral's IPO is tentatively scheduled for TBA, and shares are expected to list on the stock exchanges on 1 April 2026.
The registrar details will be confirmed in the official prospectus.
Sai Parenteral's IPO Analysis & Articles
